Kelly Raj, DO
Family Medicine · Cleveland, OHNPI 1447479472
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $2,000 of the $2,748 with a category attached, or 72.8%. Echosens North America, Inc. accounts for 72.8% of it on its own, with 18 other manufacturers making up the rest. Reporting peaked in 2023 at $2,286 and has fallen 96.9% since, to $72 in 2025.
Across 28 payments — averaging $98.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Echosens North America, Inc.$2K
- Astellas Pharma US Inc$144
- AstraZeneca$129
- Dexcom, Inc.$112
- Esperion Therapeutics, Inc.$55
- Teva Pharmaceuticals USA, Inc.$39
- plus $269 from 13 others
What the payments were for
- Speaking & faculty fees$2,00073%
- Food & beverage$74827%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Echosens North America, Inc. | 1 | $2,000 |
| Astellas Pharma US Inc | 2 | $144 |
| AstraZeneca | 1 | $129 |
| Dexcom, Inc. | 5 | $112 |
| Esperion Therapeutics, Inc. | 1 | $55 |
| Teva Pharmaceuticals USA, Inc. | 2 | $39 |
| AbbVie | 2 | $38 |
| Pfizer | 2 | $34 |
| Johnson & Johnson | 2 | $29 |
| Exact Sciences | 1 | $22 |
| Halozyme Inc | 1 | $19 |
| Corium, LLC | 1 | $18 |
| Merck | 1 | $18 |
| Sanofi Pasteur Inc. | 1 | $16 |
| Amgen | 1 | $16 |
| Boehringer Ingelheim | 1 | $16 |
| Novo Nordisk | 1 | $15 |
| GSK | 1 | $14 |
| Lilly USA, LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,748 in reported general payments places this provider in the 75th percentile of 3,983 family medicine providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TrulicityDulaglutide | 22 | $24,077 |
| EliquisApixaban | 25 | $18,820 |
| JanuviaSitagliptin Phosphate | 15 | $5,704 |
| Atorvastatin Calcium | 121 | $1,115 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 11 | $905 |
| Memantine Hcl | 35 | $847 |
| Levothyroxine Sodium | 115 | $721 |
| Omeprazole | 61 | $627 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 23 | $488 |
| Lisinopril | 79 | $462 |
| Losartan Potassium | 52 | $453 |
| Amlodipine Besylate | 90 | $444 |
| Metoprolol Succinate | 37 | $440 |
| Rosuvastatin Calcium | 38 | $397 |
| Potassium Chloride | 16 | $341 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCTrulicity | $13 | $24,07722 claims |
| PfizerEliquis | $34 | $18,82025 claims |
| MerckJanuvia | $18 | $5,70415 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 3,983 family medicine providers in Ohio.
Other family medicine in Cleveland
- Meaghan CombsCleveland$20K
- Kwabena OtengSpringdale$2M
- Brian BeesleyColumbus$1.4M
- Darshana PatelBeachwood$648K
- Thomas GraceFindlay$503K
- Susan RatayAshtabula$379K
- Shannon TrotterSpringfield$348K
- Michael HeileCincinnati$272K
- Bradley EverlyMaumee$266K
- Tricia BedrickCuyahoga Falls$259K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.